Geographic Access to Early Pregnancy Loss Management

Obstet Gynecol. 2024 Mar 1;143(3):435-439. doi: 10.1097/AOG.0000000000005505. Epub 2024 Jan 11.

Abstract

Early pregnancy loss (EPL) is common, but patients face barriers to the most effective medication (mifepristone followed by misoprostol) and procedural (uterine aspiration) management options. This cross-sectional geospatial analysis evaluated access in New Mexico to mifepristone and misoprostol and uterine aspiration in emergency departments (comprehensive) and to uterine aspiration anywhere in a hospital (aspiration) for EPL. Access was defined as a 60-minute car commute. We collected data from hospital key informants and public databases and performed logistical regression to evaluate associations between access and rurality, area deprivation, race, and ethnicity. Thirty-five of 42 (83.3%) hospitals responded between October 2020 and August 2021. Two hospitals (5.7%) provided comprehensive management; 24 (68.6%) provided aspiration. Rural and higher deprivation areas had statistically significantly lower adjusted odds ratios for comprehensive management (0.03-0.07 and 0.3-0.4, respectively) and aspiration (0.03-0.06 and 0.1-0.3, respectively) access. Mifepristone and uterine aspiration implementation would address disparate access to EPL treatment.

MeSH terms

  • Abortion, Induced*
  • Abortion, Spontaneous* / epidemiology
  • Abortion, Spontaneous* / therapy
  • Cross-Sectional Studies
  • Female
  • Humans
  • Mifepristone / therapeutic use
  • Misoprostol* / therapeutic use
  • Pregnancy
  • Respiratory Aspiration

Substances

  • Mifepristone
  • Misoprostol